NLRP3 Inflammasome assembly in microglia-induced reactive astrocytes
-
1
Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Portugal
-
2
Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Portugal
Microglia and astrocytes work together as the immune effectors in the Central Nervous System (CNS). Upon a prolonged insult or injury, these cells acquire a reactive, pro-inflammatory phenotype, resulting in neuronal damage [1]. At the core of this inflammatory response is the NLRP3 inflammasome (NLRP3), a cytosolic multiprotein complex that leads to Interleukin-1beta (IL-1beta) secretion. The canonical mechanism of NLRP3 activation involves: 1) a priming signal, which induces an increased production of pro-IL-1beta and NLRP3 protein, and 2) an activation signal, which mediates the oligomerization of the inflammasome subunits [1].
Although NLRP3 assembly in microglia is established, its presence in astrocytes remains to be confirmed. Furthermore, recent data show that microglia and astrocytes exhibit a reciprocal modulation in CNS [2]. Hence, this work aims to explore the production and assembly of NLRP3 in astrocytes and to clarify the role of microglia in these events.
To do so, primary cultures of astrocytes, microglia and co-cultures were prepared from newborn Sprague-Dawley rats. After 17 days in vitro, cells were stimulated with LPS (100ng/ml) for 24h, as the priming stimulus, with or without the oligomerization signal: ATP (1mM).
Through immunocytochemistry, morphological alterations and NLRP3 expression in astrocytes were visualized. Upon LPS/ATP stimulation, astrocytes exhibit a more reactive phenotype, confirmed by STAT3 staining [3] and an increased NLRP3 expression in co-cultures, when compared with astrocytes cultured alone.
Next, the effect of LPS/ATP stimuli on A1 astrocytes induced by microglia-derived factors, namely IL-1α (3ng/mL), TNFα (30 ng/mL) and C1q (400 ng/mL), for 24h [4] was assessed. NLRP3 assembly in reactive astrocytes was analyzed by immunocytochemistry and immunoprecipitation, while the levels of IL-1beta were assessed by ELISA.
Our preliminary results suggest that astrocyte-microglia communication is indeed important for NLRP3 assembly and activation in astrocytes. However, if cell-to-cell contact is necessary remains to be determined.
References
[1] Jha MK et al. 2018. The Neuroscientist 1–14. DOI: 10.1177/1073858418783959
[2] Guo H et al. 2015. Nature Medicine 21(7):677–87. DOI:10.1038/nm.3893
[3] Herrman et al. 2008. The Journal of Neuroscience 28(28):7231-7243. DOI:10.1523/JNEUROSCI. 1709-08.2008
[4] Liddelow SA et al. 2017. Nature 541(7638): 481–487. DOI:10.1038/nature21029
Keywords:
Astrocytes,
Microglia,
NLRP3 inflamamasome,
Neuroinflammation,
IL-1beta
Conference:
XVI Meeting of the Portuguese Society for Neuroscience (SPN2019), Lisboa, Portugal, 30 May - 1 Jun, 2019.
Presentation Type:
Poster presentation
Topic:
Glia / Neuroinflammation
Citation:
Fortunato
A,
Almeida
CC,
Sebastião
AM and
Valente
CA
(2019). NLRP3 Inflammasome assembly in microglia-induced reactive astrocytes.
Front. Cell. Neurosci.
Conference Abstract:
XVI Meeting of the Portuguese Society for Neuroscience (SPN2019).
doi: 10.3389/conf.fncel.2019.01.00019
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
16 Apr 2019;
Published Online:
27 Sep 2019.
*
Correspondence:
Prof. Ana M Sebastião, Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, 1649-028, Portugal, anaseb@medicina.ulisboa.pt
PhD. Claudia A Valente, Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, 1649-028, Portugal, cvalentecastro@medicina.ulisboa.pt